Literature DB >> 25586321

[Vitamin B12 deficiency in the elderly].

A H Leischker1, G F Kolb.   

Abstract

The prevalence of vitamin B12 deficiency increases with age. Patients with dementia and spouses of patients with dementia are at special risk for the development of vitamin B12 deficiency. In a normal diet this vitamin is present only in animal source foods; therefore, vegans frequently develop vitamin B12 deficiency if not using supplements or foods fortified with cobalamin. Apart from dementia, most of these manifestations are completely reversible under correct therapy; therefore it is crucial to identify and to treat even atypical presentations of vitamin B12 deficiency as early as possible. This article deals with the physiology and pathophysiology of vitamin B12 metabolism. A practice-oriented algorithm which also considers health economic aspects for a rational laboratory diagnosis of vitamin B12 deficiency is presented. In cases with severe neurological symptoms, therapy should be parenteral, especially initially. For parenteral treatment, hydroxocobalamin is the drug of choice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25586321     DOI: 10.1007/s00391-014-0837-0

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  76 in total

Review 1.  Diagnosing vitamin B12 deficiency, a common geriatric disorder.

Authors:  M Carethers
Journal:  Geriatrics       Date:  1988-03

2.  Long term therapy of pernicious anaemia with the depot cobalamin preparation betolvex.

Authors:  P Bastrup-Madsen; I Helleberg-Rasmussen; S Nørregaard; B Halver; T Hansen
Journal:  Scand J Haematol       Date:  1983-07

3.  Vitamin B(12) and folate in relation to the development of Alzheimer's disease.

Authors:  H X Wang; A Wahlin ; H Basun; J Fastbom; B Winblad; L Fratiglioni
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

Review 4.  Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency.

Authors:  J Vidal-Alaball; C C Butler; R Cannings-John; A Goringe; K Hood; A McCaddon; I McDowell; A Papaioannou
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

5.  Age-related hearing loss, methylmalonic acid, and vitamin B12 status in older adults.

Authors:  Sohyun Park; Mary Ann Johnson; Kelly Shea-Miller; Albert R De Chicchis; Robert H Allen; Sally P Stabler
Journal:  J Nutr Elder       Date:  2006

Review 6.  Vitamin B12 and cognitive function: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2013-11-01

Review 7.  Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis.

Authors:  L Masucci; R Goeree
Journal:  Ont Health Technol Assess Ser       Date:  2013-11-01

8.  A reversible cause of skin hyperpigmentation and postural hypotension.

Authors:  Rabia Cherqaoui; Mehreen Husain; Sujay Madduri; Pamela Okolie; Gail Nunlee-Bland; James Williams
Journal:  Case Rep Hematol       Date:  2013-06-11

9.  Effect of vitamin B12 deficiency on otoacoustic emissions.

Authors:  R Karli; A Gül; B Uğur
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

Review 10.  Cobalamin deficiency: clinical picture and radiological findings.

Authors:  Chiara Briani; Chiara Dalla Torre; Valentina Citton; Renzo Manara; Sara Pompanin; Gianni Binotto; Fausto Adami
Journal:  Nutrients       Date:  2013-11-15       Impact factor: 5.717

View more
  2 in total

Review 1.  [Clinical hematological symptoms of vitamin B12 deficiency in old age : Summarized overview of this year's symposium of the Working Group "Anemia in the Aged" on the occasion of the annual conference of the German Geriatric Society (DGG) in Frankfurt].

Authors:  Gabriele Röhrig; Ines Gütgemann; Gerald Kolb; Andreas Leischker
Journal:  Z Gerontol Geriatr       Date:  2018-05-23       Impact factor: 1.281

Review 2.  [Vitamins and nutritional supplements in older persons: How to diagnose and when to substitute?].

Authors:  D Polivka; C A F von Arnim
Journal:  Internist (Berl)       Date:  2015-11       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.